Nexstim Plc’s resolutions of the Annual General Meeting of Shareholders
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ), announces that the following resolutions were adopted at its Annual General Meeting of Shareholders held today on 11 May 2021.
1 PRESENTATION OF THE ANNUAL ACCOUNTS AND CONSOLIDATED ACCOUNTS FOR THE YEAR 2020, LOSS FOR THE FINANCIAL YEAR AND DISCHARGE FROM LIABILITY.
The Annual General Meeting of Shareholders adopted the Company s financial statements, including the consolidated financial statements for the year 2020 and resolved that no dividend is paid for the financial year 1 January – 31 December 2020 and that the loss of the financial year is recorded to the retained losses account. The Annual General Meeting discharged the members of the Board of Directors and the Managing Director from liability for the financial year 1 January – 31 December 2020.
Nexstim Oyj: Nexstim Plc s resolutions of the Annual General Meeting of Shareholders
Nexstim Plc s resolutions of the Annual General Meeting of Shareholders
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ), announces that the following resolutions were adopted at its Annual General Meeting of Shareholders held today on 11 May 2021.
1 PRESENTATION OF THE ANNUAL ACCOUNTS AND CONSOLIDATED ACCOUNTS FOR THE YEAR 2020, LOSS FOR THE FINANCIAL YEAR AND DISCHARGE FROM LIABILITY.
The Annual General Meeting of Shareholders adopted the Company s financial statements, including the consolidated financial statements for the year 2020 and resolved that no dividend is paid for the financial year 1 January - 31 December 2020 and that the loss of the financial year is recorded to the retained losses account. The Annual General Meeting discharged the members of the Board of Directors and the Managing Director from liability for the financial year 1 January - 31 December 2020.
LaingBuisson News
Former CEO and president of The Revenio Group, Timo Hildén, has been appointed chairman of the board of directors at Finnish medtech startup, Nukute.
Nukute develops high-tech tools for the diagnosis and testing of respiratory diseases and conditions, including the home sleep apnea testing (HSAT) product.
Alongside Hildén, Nukute appointed another two new members to the board: Tommi Mäkelä as the representative of the Pharmacy Pension Fund (Finland), and Frans Wuite, CEO of Kompassi. Johannes Gullichsen, Pekka Virtanen and Timo Laitinen continue as members.
“Nukute demonstrates well the high level of medical technology innovation found in Finland today. The next couple of years will be very interesting as Nukute begins its commercial growth both in Finland and abroad and as it receives more and more clinical interest and acceptance,” said Hildén.
Investegate |Nexstim Oyj Announcements | Nexstim Oyj: Correction to the Invitation to the Annual General Meeting of Nexstim Plc investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Nexstim Oyj: Correction to the Invitation to the Annual General Meeting of Nexstim Plc
Correction to the Invitation to the Annual General Meeting of Nexstim Plc
In accordance with the invitation to the Annual General Meeting of Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ) dated 15 April 2021, the shareholders of the Company have been invited to the Annual General Meeting to be held on 11 May 2021 commencing at 12.00 (EEST).
The invitation to the meeting of 15 April 2021 includes a writing error stating that transfers of shares from the Company to the Receiving Shareholders required for the final adjustments of their number of shares (after reduction) are expected to take place and be recorded in book-entry accounts at the latest on 17th May 2021 in Sweden and 19th May 2021 in Finland. Notwithstanding the above-mentioned, the transfers of shares are expected to take place and be recorded in book-entry accounts at the latest on 17th May 2021 in Finland and 19th May 20